Tumor-Associated Embryonic Antigen-Expressing Vaccines that Target CCR6 Elicit Potent CD8(+) T Cell-Mediated Protective and Therapeutic Antitumor Immunity

Documenti analoghi

• CCR4-Expressing T Cell Tumors Can Be Specifically Controlled via Delivery of Toxins to Chemokine Receptors
  di: Baatar, Dolgor, et al.
  Pubblicazione: (2007)
• Human Peripheral Blood T Regulatory Cells (Tregs), Functionally Primed CCR4(+) Tregs and Unprimed CCR4(−) Tregs, Regulate Effector T Cells Using FasL
  di: Baatar, Dolgor, et al.
  Pubblicazione: (2007)
• Chemokine receptor targeting efficiently directs antigens to MHC class I pathways and elicits antigen-specific CD8(+) T-cell responses
  di: Schiavo, Roberta, et al.
  Pubblicazione: (2006)
• Tregs utilize β-galactoside-binding protein to transiently inhibit PI3K/p21(ras) activity of human CD8(+) T cells to block their TCR-mediated ERK activity and proliferation
  di: Baatar, Dolgor, et al.
  Pubblicazione: (2009)
• Breast cancer lung metastasis requires expression of chemokine receptor CCR4 and T regulatory cells
  di: Olkhanud, Purevdorj B., et al.
  Pubblicazione: (2009)